Utility of immunohistochemical markers in irradiated breast tissue

An analysis of the role of myoepithelial markers, p53, and Ki-67

Kaeley Anderson, Elizabeth M. Williams, Josh Kaplan, Linh Matsumura, Megan Troxell

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Radiation therapy is an important adjunct to breast-conserving surgery, but the diagnosis of recurrent/de novo carcinoma in a background of radiation atypia can be difficult, especially on small biopsies. Immunostaining for myoepithelial cell proteins is often used to assess invasion in nonirradiated breast tissue, yet these stains have not been investigated specifically in irradiated breast. We studied 29 irradiated breast resection specimens, some with carcinoma in situ (CIS, n=13) and/or invasive carcinoma (n=13). Representative blocks were stained for the myoepithelial proteins p63, smooth muscle myosin heavy chain (SMM), calponin, CK5/6, the proliferative marker Ki-67, and the tumor-suppressor p53. Nonirradiated control tissue was also stained with Ki-67 and p53 (CIS, normal, contralateral). Areas of radiation atypia/atrophy and nearly all CIS in irradiated breast tissue had abundant myoepithelial cells as evidenced by SMM, calponin, and p63 stains, with focal staining attenuation or gaps with SMM and calponin and frequently absent CK5/6 staining. As predicted, myoepithelial cell staining was absent in invasive carcinoma. p63 staining revealed postradiation myoepithelial nuclear morphologic changes. p53 staining was increased, although weak, in irradiated non-neoplastic breast (12% irradiated; 4% nonirradiated); however, irradiated CIS had less p53 staining when compared with control CIS (3% irradiated; 38% nonirradiated). As expected, Ki-67 was increased in carcinoma as compared with non-neoplastic irradiated tissue. Thus, myoepithelial immunostaining is a useful diagnostic adjunct in irradiated breast, with caveats similar to nonirradiated breast. Ki-67 may be helpful in some postradiation specimens; however, p53 staining is not reliable in this setting.

Original languageEnglish (US)
Pages (from-to)1128-1137
Number of pages10
JournalAmerican Journal of Surgical Pathology
Volume38
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Breast
Staining and Labeling
Carcinoma
Coloring Agents
Smooth Muscle Myosins
Background Radiation
Segmental Mastectomy
Myosin Heavy Chains
Carcinoma in Situ
Atrophy
Proteins
Radiotherapy
Radiation
Biopsy
calponin
Neoplasms

Keywords

  • Breast cancer
  • Ki-67
  • myoepithelial immunohistochemistry
  • p53
  • radiation therapy

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Utility of immunohistochemical markers in irradiated breast tissue : An analysis of the role of myoepithelial markers, p53, and Ki-67. / Anderson, Kaeley; Williams, Elizabeth M.; Kaplan, Josh; Matsumura, Linh; Troxell, Megan.

In: American Journal of Surgical Pathology, Vol. 38, No. 8, 2014, p. 1128-1137.

Research output: Contribution to journalArticle

Anderson, Kaeley ; Williams, Elizabeth M. ; Kaplan, Josh ; Matsumura, Linh ; Troxell, Megan. / Utility of immunohistochemical markers in irradiated breast tissue : An analysis of the role of myoepithelial markers, p53, and Ki-67. In: American Journal of Surgical Pathology. 2014 ; Vol. 38, No. 8. pp. 1128-1137.
@article{e419dff56c604cea93044bcdbb836580,
title = "Utility of immunohistochemical markers in irradiated breast tissue: An analysis of the role of myoepithelial markers, p53, and Ki-67",
abstract = "Radiation therapy is an important adjunct to breast-conserving surgery, but the diagnosis of recurrent/de novo carcinoma in a background of radiation atypia can be difficult, especially on small biopsies. Immunostaining for myoepithelial cell proteins is often used to assess invasion in nonirradiated breast tissue, yet these stains have not been investigated specifically in irradiated breast. We studied 29 irradiated breast resection specimens, some with carcinoma in situ (CIS, n=13) and/or invasive carcinoma (n=13). Representative blocks were stained for the myoepithelial proteins p63, smooth muscle myosin heavy chain (SMM), calponin, CK5/6, the proliferative marker Ki-67, and the tumor-suppressor p53. Nonirradiated control tissue was also stained with Ki-67 and p53 (CIS, normal, contralateral). Areas of radiation atypia/atrophy and nearly all CIS in irradiated breast tissue had abundant myoepithelial cells as evidenced by SMM, calponin, and p63 stains, with focal staining attenuation or gaps with SMM and calponin and frequently absent CK5/6 staining. As predicted, myoepithelial cell staining was absent in invasive carcinoma. p63 staining revealed postradiation myoepithelial nuclear morphologic changes. p53 staining was increased, although weak, in irradiated non-neoplastic breast (12{\%} irradiated; 4{\%} nonirradiated); however, irradiated CIS had less p53 staining when compared with control CIS (3{\%} irradiated; 38{\%} nonirradiated). As expected, Ki-67 was increased in carcinoma as compared with non-neoplastic irradiated tissue. Thus, myoepithelial immunostaining is a useful diagnostic adjunct in irradiated breast, with caveats similar to nonirradiated breast. Ki-67 may be helpful in some postradiation specimens; however, p53 staining is not reliable in this setting.",
keywords = "Breast cancer, Ki-67, myoepithelial immunohistochemistry, p53, radiation therapy",
author = "Kaeley Anderson and Williams, {Elizabeth M.} and Josh Kaplan and Linh Matsumura and Megan Troxell",
year = "2014",
doi = "10.1097/PAS.0000000000000243",
language = "English (US)",
volume = "38",
pages = "1128--1137",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Utility of immunohistochemical markers in irradiated breast tissue

T2 - An analysis of the role of myoepithelial markers, p53, and Ki-67

AU - Anderson, Kaeley

AU - Williams, Elizabeth M.

AU - Kaplan, Josh

AU - Matsumura, Linh

AU - Troxell, Megan

PY - 2014

Y1 - 2014

N2 - Radiation therapy is an important adjunct to breast-conserving surgery, but the diagnosis of recurrent/de novo carcinoma in a background of radiation atypia can be difficult, especially on small biopsies. Immunostaining for myoepithelial cell proteins is often used to assess invasion in nonirradiated breast tissue, yet these stains have not been investigated specifically in irradiated breast. We studied 29 irradiated breast resection specimens, some with carcinoma in situ (CIS, n=13) and/or invasive carcinoma (n=13). Representative blocks were stained for the myoepithelial proteins p63, smooth muscle myosin heavy chain (SMM), calponin, CK5/6, the proliferative marker Ki-67, and the tumor-suppressor p53. Nonirradiated control tissue was also stained with Ki-67 and p53 (CIS, normal, contralateral). Areas of radiation atypia/atrophy and nearly all CIS in irradiated breast tissue had abundant myoepithelial cells as evidenced by SMM, calponin, and p63 stains, with focal staining attenuation or gaps with SMM and calponin and frequently absent CK5/6 staining. As predicted, myoepithelial cell staining was absent in invasive carcinoma. p63 staining revealed postradiation myoepithelial nuclear morphologic changes. p53 staining was increased, although weak, in irradiated non-neoplastic breast (12% irradiated; 4% nonirradiated); however, irradiated CIS had less p53 staining when compared with control CIS (3% irradiated; 38% nonirradiated). As expected, Ki-67 was increased in carcinoma as compared with non-neoplastic irradiated tissue. Thus, myoepithelial immunostaining is a useful diagnostic adjunct in irradiated breast, with caveats similar to nonirradiated breast. Ki-67 may be helpful in some postradiation specimens; however, p53 staining is not reliable in this setting.

AB - Radiation therapy is an important adjunct to breast-conserving surgery, but the diagnosis of recurrent/de novo carcinoma in a background of radiation atypia can be difficult, especially on small biopsies. Immunostaining for myoepithelial cell proteins is often used to assess invasion in nonirradiated breast tissue, yet these stains have not been investigated specifically in irradiated breast. We studied 29 irradiated breast resection specimens, some with carcinoma in situ (CIS, n=13) and/or invasive carcinoma (n=13). Representative blocks were stained for the myoepithelial proteins p63, smooth muscle myosin heavy chain (SMM), calponin, CK5/6, the proliferative marker Ki-67, and the tumor-suppressor p53. Nonirradiated control tissue was also stained with Ki-67 and p53 (CIS, normal, contralateral). Areas of radiation atypia/atrophy and nearly all CIS in irradiated breast tissue had abundant myoepithelial cells as evidenced by SMM, calponin, and p63 stains, with focal staining attenuation or gaps with SMM and calponin and frequently absent CK5/6 staining. As predicted, myoepithelial cell staining was absent in invasive carcinoma. p63 staining revealed postradiation myoepithelial nuclear morphologic changes. p53 staining was increased, although weak, in irradiated non-neoplastic breast (12% irradiated; 4% nonirradiated); however, irradiated CIS had less p53 staining when compared with control CIS (3% irradiated; 38% nonirradiated). As expected, Ki-67 was increased in carcinoma as compared with non-neoplastic irradiated tissue. Thus, myoepithelial immunostaining is a useful diagnostic adjunct in irradiated breast, with caveats similar to nonirradiated breast. Ki-67 may be helpful in some postradiation specimens; however, p53 staining is not reliable in this setting.

KW - Breast cancer

KW - Ki-67

KW - myoepithelial immunohistochemistry

KW - p53

KW - radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84904507764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904507764&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000243

DO - 10.1097/PAS.0000000000000243

M3 - Article

VL - 38

SP - 1128

EP - 1137

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 8

ER -